CGH, or Comparative Genomic Hybridization, is a valuable tool we offer during IVF to ensure you’re getting the most from your treatment here at New Hope Fertility Center.
Although we’ve been offering PGD testing since 2004, we’ve partnered with PGD experts, Reprogenetics, in the last couple of years to provide you with the latest in embryo-testing technology.
Unlike the past — when PGD was used for gender selection and finding only specific chromosomal abnormalities — our latest CGH testing is the most comprehensive test you can use in an effort to detect significant genetic abnormalities.
If you or your partner have experience with genetic disorders in your family or simply need the security that comes from utilizing the best resources available, it is important to consider the use of CGH testing during your treatment. Not only does this state-of-the-art technology make IVF safer, as we’re reducing the risk of pregnancy loss, but also reduces the chance (and cost) of multiple cycles since we’re transferring only the healthiest embryos.
The availability of CGH testing also allows our center to highlight the benefits of our less is more philosophy, which focuses on single embryo transfers to reduce the chance of multiple pregnancies. Transferring multiple embryos and resulting multiple pregnancies/births are stressful on the uterine environment, significantly decreasing the chance of a healthy pregnancy and increasing the chance of premature births. With CGH, we virtually wipe out these concerns, since we’re selecting, freezing and transferring only the most mature and robust embryos that are undoubtedly free of chromosomal abnormalities.
We’d say “welcome to the future of IVF,” but it seems we’re already there!
For more information on our minimally invasive approach to IVF with CGH testing, please visit us on the web to schedule a consultation.